FreeStyle Libre 3 Plus Sensor

      Introducing the FreeStyle Libre 3 Plus sensor from Abbott, the world’s smallest, thinnest, and most discreet sensor for continuous glucose monitoring. This innovative device now offers an extended wear-time of 15 days and is designed for future connectivity with automated insulin delivery (AID) systems, making diabetes management more seamless and efficient.

      Cleared by the Food and Drug Administration (FDA) in 2023, the FreeStyle Libre 3 Plus sensor is an enhanced version of the Libre 3 sensor. It’s suitable for individuals aged 2 years and older, providing a convenient wear-time of 15 days without the need for scanning.

      Users can effortlessly monitor their glucose levels by pairing the Libre 3 Plus sensor with the Libre 3 system’s smartphone app or reader. Once paired, the latest glucose information is automatically available upon opening the app or when an alarm notification is received, offering real-time data and alerts that enhance diabetes management.

      The FreeStyle Libre 3 Plus sensor represents a significant advancement in continuous glucose monitoring technology, promising improved quality of life for people managing diabetes. With its extended wear-time and compatibility with AID systems, it sets a new standard for discreet and reliable glucose monitoring.